Among patients hospitalised for advanced lung cancer, the prescription of preventative medicines for diabetes, hypertension, hyperlipidemia, antiplatelet agents, and vitamins/minerals is very common not only at the moment of admission, but also at discharge, according [more]
Some commonly used statistical concepts are hard to master not only for most patients, but for many professionals as well. Especially when it comes to cancer screening A common assumption, when addressing informed decision making [more]
Physicians seem to accommodate to patients’ requests of second opinions trying not to harm neither the relationship with patients themselves nor with colleagues. Oncologists usually cooperate among each other, even though they do not often [more]
Clinicians around the world use NCCN Clinical Practice Guidelines in Oncology as a standard for clinical decision-making. The NCCN Harmonized Guidelines are targeted regional resources created as part of a collaborative effort to combat the [more]
In June of this year I finally completed more than a year of gruelling treatment for breast cancer, which started with a double mastectomy and continued with various types of chemotherapy. I will be taking [more]
For many patients newly diagnosed with cancer, financial toxicity should be on top of the list of their doctors concerns: according to a US survey described on the peer-reviewed journal Cancer, published by the American Cancer [more]
A blood test that can predict how men with advanced prostate cancer will respond to specific treatments has been validated in a multi-institution cohort study, recently published on Jama Oncology by an International group coordinated [more]
In February this year there was a significant announcement from the European Commission – the Joint Research Centre (JRC) launched the European Cancer Information System (ECIS), the result of several years’ work to integrate data from European cancer [more]
If the 181 entries to this year’s Cancer World Journalism Award proved anything, it was that journalists are putting cancer on the agenda in every corner of the world. Articles and programmes were submitted from [more]
Is the paradigm of cancer treatment bound to change? At a time when new drugs are registered for use on a specific molecular target instead of a specific tumor, experts raise some warnings: this new [more]
Cancer patients who use complementary medicine tend to refuse effective treatments more often than non users, and this reflects on increased mortality: this is the conclusion of an observational study just published on Jama Oncology, that [more]
A research letter just published in the journal Nature by an International group of researchers directed by Grace Collord of the Wellcome Sanger Institute and University of Cambridge, in England, “provides proof-of-principle that it may be possible to develop [more]
It’s not just a matter of clinical outcomes: quality of life goes far beyond the final result of a cancer treatment and involves several aspects of daily life, both for patients and their caregivers. And [more]